A B-cell-restricted Dnmt3a knockout mouse model demonstrated that loss of DNMT3A expression was able to drive the development of CLL and was related to aggressive disease, Notch and Myc signaling activation, and Notch inhibition sensitivity enhancement [36]. This evidence concerns the gene MYC and B-cell chronic lymphocytic leukemia.